Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (6)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

496 result(s) found, displaying 51 to 60

LEVOTHYROXINE SCP levothyroxine sodium 150 microgram un-coated tablet blister pack (374940)

23 December 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVOTHYROXINE SCP levothyroxine sodium 150 microgram un-coated tablet blister pack.
LEVOTHYROXINE SCP levothyroxine sodium 200 microgram un-coated tablet blister pack (374941)

23 December 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVOTHYROXINE SCP levothyroxine sodium 200 microgram un-coated tablet blister pack.
LEVOTHYROXINE SCP levothyroxine sodium 125 microgram un-coated tablet blister pack (374939)

23 December 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVOTHYROXINE SCP levothyroxine sodium 125 microgram un-coated tablet blister pack.
BETAHISTINE LUPIN betahistine dihydrochloride 16mg tablet blister pack (388870)

13 October 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BETAHISTINE LUPIN betahistine dihydrochloride 16mg tablet blister pack.
LORAZEPAM LUPIN lorazepam 1 mg tablet blister pack (389601)

15 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZEPAM LUPIN lorazepam 1 mg tablet blister pack.
LORAZEPAM LUPIN lorazepam 2.5 mg tablet blister pack (389602)

15 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LORAZEPAM LUPIN lorazepam 2.5 mg tablet blister pack.
BTC CLOPIDOGREL clopidogrel (as besilate) 75 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
ANASTROZOLE FBM anastrozole 1mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LEVOTHYROXINE AJS levothyroxine sodium 125 microgram un-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LEVOTHYROXINE AJS levothyroxine sodium 100 microgram un-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.